Printer Friendly
The Free Library
4,553,008 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

ADVISORY/Photo of the CONTAK/EASYTRAK system is Available on NewsCom, PressLink and on Business Wire's Web site at www.businesswire.com.


Photo/Business & Health/Medical Editors

ADVISORY...

--(BW HealthWire)

The photo is on Business Wire's Web Site at

http://www.businesswire.com/cgi-bin/photo.cgi?pw.050201/bw1

Photo caption reads:

INDIANAPOLIS and St. Paul St. Paul

as a missionary he fearlessly confronts the “perils of waters, of robbers, in the city, in the wilderness.” [N.T.: II Cor. 11:26]

See : Bravery
, MN - May 2, 2001 - Results of the CONTAK CD(TM) trial show that patients receiving Guidant Corporation's (NYSE NYSE

See: New York Stock Exchange
 and PCX (1) A bitmapped graphics file format that handles monochrome, 2-bit, 4-bit, 8-bit and 24-bit color and uses RLE to achieve compression ratios of approximately 1.1:1 to 1.5:1. Images with large blocks of solid colors compress best under the RLE method. See PC Paintbrush. :GDT GDT Global Descriptor Table
GDT Geographic Data Technology Inc.
GDT Gas Discharge Tube (energy, electrotechinical and electronics)
GDT Getting Things Done
GDT Geometric Dimensioning & Tolerancing
GDT Ground Data Terminal
) new heart failure therapy -- the CONTAK/EASYTRAK system -- experience slowing of heart failure progression, increased quality of life and significant improvement in functional capacity. The data will be presented this evening at a symposium held in conjunction with the 22nd Annual Scientific Sessions of the North American North American

named after North America.


North American blastomycosis
see North American blastomycosis.

North American cattle tick
see boophilusannulatus.
 Society of Pacing and Electrophysiology in Boston. (Business Wire photo)
CONTACT: Guidant Corp., Andy Rieth, Investor Relations, 317/971-2061; Kristi
Fuller, Media Relations, 651/582-5201; Steven Tragash, Media Relations,
408/845-3287. Rowland Communications, Scott Lerman, 212/527-8921 (office),
917/324-1719 (on-site at NASPE meeting)


See BW2106 for more information.
COPYRIGHT 2001 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2001, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:May 2, 2001
Words:151
Previous Article:ADVISORY/ Tennessee Titans Head Coach Jeff Fisher to Visit Hunters Bend Elementary School and Present School with a $5,000 Staples Gift Certificate.
Next Article:FOCUS Enhancements Reports Year End Results for 2000; Provides Q1 2001 Guidance.
Topics:



Related Articles
Guidant Announces Start of COMPANION Study Evaluating Treatment of Chronic Heart Failure.
ADVISORY/Photo of Guidant's CONTAK(tm) CD pulse generator, CONTAK TR pulse generator, and EASYTRAK(tm) lead is available on BW PhotoWire/AP...
Guidant Announces Start of PACMAN Study To Further Evaluate Novel Heart Failure Treatment.
ADVISORY/Photos of Guidant's CONTAK(tm) CD and TR pulse generators and the EASYTRAK(tm) lead are available on BW PhotoWire/AP PhotoExpress, NewsCom,...
Guidant Announces Completion of Milestone in Heart Failure Clinical Study.
Guidant Announces FDA Filing for Heart Failure Treatment; Company First to File for Approval of Cardiac Resynchronization Therapy Defibrillator for...
Guidant's Heart Failure Trial Supports Benefits of the Combination of Cardiac Resynchronization and Defibrillation Therapies.
Guidant Provides Product Updates at Annual Meeting of Shareholders; Emerging Therapies Position Company for Future Success.
Guidant Announces CE Mark Approval of Next Generation Lead for Use with Heart Failure Devices; Innovative Lead Instrumental in Delivering Therapy for...
FDA Approves Guidant's System for the Treatment of Heart Failure.

Terms of use | Copyright © 2008 Farlex, Inc. | Feedback | For webmasters | Submit articles